Fujian Cosunter Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 173.317 million compared to CNY 173.237 million a year ago. Operating loss was CNY 20.922 million compared to operating Income of CNY 12.857 million a year ago. Net loss was CNY 17.097 million compared to net income of CNY 11.371 million a year ago. Basic loss per share from continuing operations was CNY 0.1221 compared to basic earnings per share from continuing operations of CNY 0.0812 a year ago.